Answers are grounded in this paper and cite their sources.
Listeria monocytogenes has recently been exploited as a vector for targeting antigens to the immune system. In the past year it has been shown to be particularly effective as a tumor antigen vector. Here we set its potency as a cancer vaccine in the context of the type of immunity induced by this facultative intracellular bacterium.
No takes yet. Share an insight, caveat, or question.
Paterson et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: